Deng et al. found that recombinant CCL2 down-regulated TNFSF15 expression, which is a negative regulator of neovascularization, thus promoting tumor angiogenesis and accelerating ovarian cancer expansion [51]. This evidence concerns the gene CCL2 and ovarian carcinoma.